The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for JE Knox


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of RMC-5552, a Selective Bi-Steric Inhibitor of mTORC1, for the Treatment of mTORC1-Activated Tumors.EBI
Revolution Medicines
Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors.EBI
Novartis Institute For Tropical Diseases
ADENOSINE A2A AND A2B RECEPTOR DUAL ANTAGONISTS FOR IMMUNO-ONCOLOGYBDB
Merck Sharp & Dohme
Selective D3 dopamine receptor agonists and methods of their useBDB
The United States of America, As Represented By The Secretary, Department of Health and Human Services
3,3-difluoropiperidine carbamate heterocyclic compounds as NR2B NMDA receptor antagonistsBDB
Rugen Holdings (Cayman)
Benzimidazoles and indoles as taro inhibitorsBDB
Merck Sharp & Dohme
Heterocyclic derivatives as PI3K inhibitorsBDB
Incyte
Piperidines as covalent menin inhibitorsBDB
University of Michigan
Urea-substituted aromatic ring-linked dioxane-quinazoline and -linked dioxane-quinoline compounds, preparation method therefor and use thereofBDB
Beijing Scitech-Mq Pharmaceuticals
FGFR3 fusion gene and pharmaceutical drug targeting sameBDB
Chugai Seiyaku Kabushiki Kaisha